Photodynamic therapy of cerebral glioma - A review Part II - Clinical studies

Journal of Clinical Neuroscience

Volumn 13, Issue 7, 2006, Pages 709-717

  Stylli, Stanley S ^a   Kaye, Andrew H ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Brain tumours; Glioma; Haematoporphyrin; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; BENZOPORPHYRIN DERIVATIVE; HEMATOPORPHYRIN DERIVATIVE; LUTETIUM TEXAPHYRIN; PHOTOFRIN; PHOTOSENSITIZING AGENT; PHTHALOCYANINE ALUMINUM; PHTHALOCYANINE DERIVATIVE; PORPHYRIN; PORPHYRIN DERIVATIVE; PURLYTIN; STEROID; TALAPORFIN; TEMOPORFIN; TETRAKIS(3 HYDROXYPHENYL)CHLORINE; UNCLASSIFIED DRUG;

ADENOCARCINOMA; BARRETT ESOPHAGUS; BASAL CELL CARCINOMA; BILE DUCT CARCINOMA; BRAIN EDEMA; BRAIN TUMOR; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; DOSE RESPONSE; DOSIMETRY; GLIOMA; HUMAN; HYPOPHYSIS ADENOMA; IRRADIATION; LABORATORY; LIGHT; LIGHT EMITTING DIODE; LOW LEVEL LASER THERAPY; OVARY CANCER; PAPILLARY CARCINOMA; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PHOTOTOXICITY; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SHORT SURVEY; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; TRANSITIONAL CELL CARCINOMA; TUMOR CELL; TUMOR CELL DESTRUCTION; UTERINE CERVIX CARCINOMA IN SITU;

ANIMALS; BRAIN NEOPLASMS; CLINICAL TRIALS; CLINICAL TRIALS AS TOPIC; GLIOMA; HUMANS; PHOTOCHEMOTHERAPY;

EID: 33748467188     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2005.11.012     Document Type: Short Survey

References (154)

1. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., and Thun M.J. Cancer statistics 2003. CA Cancer J Clin 53 (2003) 5-26
2. Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E., et al. Cancer statistics, 2004. CA Cancer J Clin 54 (2004) 8-29
3. Wallner K.E., Galicich J.H., Krol G., Arbit E., and Malkin M.G. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16 (1989) 1405-1409
4. Senger D., Cairncross J.G., and Forsyth P.A. Long-term survivors of glioblastoma: statistical aberration or important unrecognized molecular subtype?. Cancer J 9 (2003) 214-221
5. Walker M.D., Alexander Jr. E., Hunt W.E., et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas A cooperative clinical trial. J Neurosurg 49 (1978) 333-343
6. Stylli SS, Kaye AH. Photodynamic therapy of cerebral glioma - a review. Part I - A biological basis. J Clin Neurosci (in press).
7. Wenig B.L., Kurtzman D.M., Grossweiner L.I., et al. Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 116 (1990) 1267-1270
8. Kashtan H., Papa M.Z., Wilson B.C., Deutch A.A., and Stern H.S. Use of photodynamic therapy in the palliation of massive advanced rectal cancer. Phase I/II study. Dis Colon Rectum 34 (1991) 600-604
9. Lobraico R.V., and Grossweiner L.I. Clinical experiences with photodynamic therapy for recurrent malignancies of the lower female genital tract. J Gynecol Surg 9 (1993) 29-34
10. Marcon N.E. Photodynamic therapy and cancer of the esophagus. Semin Oncol 21 (1994) 20-23
11. Lam S. Photodynamic therapy of lung cancer. Semin Oncol 21 (1994) 15-19
12. Takita H., Mang T.S., Loewen G.M., et al. Operation and intracavitary photodynamic therapy for malignant pleural mesothelioma: a phase II study. Ann Thorac Surg 58 (1994) 995-998
13. Nseyo U.O. Photodynamic therapy in the management of bladder cancer. J Clin Laser Med Surg 14 (1996) 271-280
14. Overholt B.F., and Panjehpour M. Photodynamic therapy in Barrett's esophagus. J Clin Laser Med Surg 14 (1996) 245-249
15. Mimura S., Narahara H., Uehara H., Otani T., and Okuda S. [Photodynamic therapy for gastric cancer]. Gan To Kagaku Ryoho 23 (1996) 41-46
16. Chang S.C., and Bown S.G. Photodynamic therapy: applications in bladder cancer and other malignancies. J Formos Med Assoc 96 (1997) 853-863
17. Bernstein Z.P., Wilson B.D., Oseroff A.R., et al. Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi's sarcoma. AIDS 13 (1999) 1697-1704
18. Marks P.V., Belchetz P.E., Saxena A., et al. Effect of photodynamic therapy on recurrent pituitary adenomas: clinical phase I/II trial-an early report. Br J Neurosurg 14 (2000) 317-325
19. Greenwald B.D. Photodynamic therapy for esophageal cancer. Update. Chest Surg Clin N Am 10 (2000) 625-637
20. Lightdale C.J. Role of photodynamic therapy in the management of advanced esophageal cancer. Gastrointest Endosc Clin N Am 10 (2000) 397-408
21. Vicente M.G. Porphyrin-based sensitizers in the detection and treatment of cancer: recent progress. Curr Med Chem Anti-Canc Agents 1 (2001) 175-194
22. Metz J.M., and Friedberg J.S. Endobronchial photodynamic therapy for the treatment of lung cancer. Chest Surg Clin N Am 11 (2001) 829-839
23. Menon C., Kutney S.N., Lehr S.C., et al. Vascularity and uptake of photosensitizer in small human tumor nodules: implications for intraperitoneal photodynamic therapy. Clin Cancer Res 7 (2001) 3904-3911
24. Ortner M. Photodynamic therapy for cholangiocarcinoma. J Hepatobiliary Pancreat Surg 8 (2001) 137-139
25. Bauer T.W., Hahn S.M., Spitz F.R., Kachur A., Glatstein E., and Fraker D.L. Preliminary report of photodynamic therapy for intraperitoneal sarcomatosis. Ann Surg Oncol 8 (2001) 254-259
26. Allison R., Mang T., Hewson G., Snider W., and Dougherty D. Photodynamic therapy for chest wall progression from breast carcinoma is an underutilized treatment modality. Cancer 91 (2001) 1-8
27. Dima V.F., Ionescu M.D., Balotescu C., and Dima S.F. Photodynamic therapy and some clinical applications in oncology. Roum Arch Microbiol Immunol 61 (2002) 159-205
28. Shieh S., Dee A.S., Cheney R.T., Frawley N.P., Zeitouni N.C., and Oseroff A.R. Photodynamic therapy for the treatment of extramammary Paget's disease. Br J Dermatol 146 (2002) 1000-1005
29. Li L.B., Luo R.C., Liao W.J., et al. [Clinical study of Photofrin photodynamic therapy for advanced cancers]. Di Yi Jun Yi Da Xue Xue Bao 23 (2003) 1341-1343
30. Prosst R.L., Wolfsen H.C., and Gahlen J. Photodynamic therapy for esophageal diseases: a clinical update. Endoscopy 35 (2003) 1059-1068
31. Manyak M.J., and Ogan K. Photodynamic therapy for refractory superficial bladder cancer: long-term clinical outcomes of single treatment using intravesical diffusion medium. J Endourol 17 (2003) 633-639
32. Moghissi K., and Dixon K. Photodynamic therapy (PDT) in esophageal cancer: a surgical view of its indications based on 14 years experience. Technol Cancer Res Treat 2 (2003) 319-326
33. Eljamel M.S. New light on the brain: The role of photosensitizing agents and laser light in the management of invasive intracranial tumors. Technol Cancer Res Treat 2 (2003) 303-309
34. Muschter R. Photodynamic therapy: a new approach to prostate cancer. Curr Urol Rep 4 (2003) 221-228
35. Zimcik P., and Miletin M. [Photodynamic therapy as a new prospective method for cancer treatment-II. Overview of photosensitizers]. Ceska Slov Farm 53 (2004) 271-279
36. Wolfsen H.C., Hemminger L.L., Wallace M.B., and Devault K.R. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer. Aliment Pharmacol Ther 20 (2004) 1125-1131
37. Schenkman E., and Lamm D.L. Superficial bladder cancer therapy. Scientific World Journal 4 Suppl 1 (2004) 387-399
38. Ion R.M., Ionita M.A., Carstocea B., Pascu M.L., Danaila L., and Bucur A. Clinical aspects of photodynamic therapy-Romanian experience. Oftalmologia 48 (2004) 53-61
39. Gerber-Leszczyszyn H., Ziolkowski P., and Marszalik P. Photodynamic therapy of head and neck tumors and non-tumor like disorders. Otolaryngol Pol 58 (2004) 339-343
40. Ortner M.A. Photodynamic therapy in cholangiocarcinomas. Best Pract Res Clin Gastroenterol 18 (2004) 147-154
41. Usui M., Miyagi M., Fukasawa S., et al. A first trial in the clinical application of photodynamic therapy for the prevention of restenosis after coronary-stent placement. Lasers Surg Med 34 (2004) 235-241
42. Cuenca R.E., Allison R.R., Sibata C., and Downie G.H. Breast cancer with chest wall progression: treatment with photodynamic therapy. Ann Surg Oncol 11 (2004) 322-327
43. Lightdale C.J., Heier S.K., Marcon N.E., et al. Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest Endosc 42 (1995) 507-512
44. Edell E.S., and Cortese D.A. Photodynamic therapy for early stage lung cancer. J Clin Laser Med Surg 9 (1991) 391-393
45. Cortese D.A., Edell E.S., and Kinsey J.H. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc 72 (1997) 595-602
46. Edell E.S., and Cortese D.A. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 102 (1992) 1319-1322
47. Furuse K., Fukuoka M., Kato H., et al. A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group. J Clin Oncol 11 (1993) 1852-1857
48. Sakai H., Okunaka T., Konaka C., and Kato H. [Photodynamic therapy for early stage lung cancer]. Nippon Rinsho 54 (1996) 1332-1336
49. Overholt B.F., and Panjehpour M. Photodynamic therapy for Barrett's esophagus. Gastrointest Endosc Clin N Am 7 (1997) 207-220
50. Overholt B.F., and Panjehpour M. Photodynamic therapy for Barrett's esophagus: clinical update. Am J Gastroenterol 91 (1996) 1719-1723
51. Biel M.A. Photodynamic therapy and the treatment of head and neck cancers. J Clin Laser Med Surg 14 (1996) 239-244
52. Biel M.A. Photodynamic therapy as an adjuvant intraoperative treatment of recurrent head and neck carcinomas. Arch Otolaryngol Head Neck Surg 122 (1996) 1261-1265
53. Nseyo U.O. Photodynamic therapy. Urol Clin North Am 19 (1992) 591-599
54. Tochner Z.A., Pass H.I., Smith P.D., et al. Intrathoracic photodynamic therapy: a canine normal tissue tolerance study and early clinical experience. Lasers Surg Med 14 (1994) 118-123
55. Tochner Z.A. Photodynamic therapy for peritoneal carcinomatosis. Cancer Treat Res 70 (1994) 83-91
56. Takita H., and Dougherty T.J. Intracavitary photodynamic therapy for malignant pleural mesothelioma. Semin Surg Oncol 11 (1995) 368-371
57. DeLaney T.F., Sindelar W.F., Tochner Z., et al. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int J Radiat Oncol Biol Phys 25 (1993) 445-457
58. Mang T.S., Allison R., Hewson G., Snider W., and Moskowitz R. A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. Cancer J Sci Am 4 (1998) 378-384
59. Kaplan M.J., Somers R.G., Greenberg R.H., and Ackler J. Photodynamic therapy in the management of metastatic cutaneous adenocarcinomas: case reports from phase 1/2 studies using tin ethyl etiopurpurin (SnET2). J Surg Oncol 67 (1998) 121-125
60. Woodburn K.W., Fan Q., Miles D.R., Kessel D., Luo Y., and Young S.W. Localization and efficacy analysis of the phototherapeutic lutetium texaphyrin (PCI-0123) in the murine EMT6 sarcoma model. Photochem Photobiol 65 (1997) 410-415
61. Woodburn K.W., Fan Q., Kessel D., Luo Y., and Young S.W. Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin. J Invest Dermatol 110 (1998) 746-751
62. Hammer-Wilson M.J., Ghahramanlou M., and Berns M.W. Photodynamic activity of lutetium-texaphyrin in a mouse tumor system. Lasers Surg Med 24 (1999) 276-284
63. Rockson S.G. Lutetium texaphyrin: a new therapeutic tool for human atherosclerosis. Curr Treat Options Cardiovasc Med 1 (1999) 199-202
64. Blumenkranz M.S., Woodburn K.W., Qing F., Verdooner S., Kessel D., and Miller R. Lutetium texaphyrin (Lu-Tex): a potential new agent for ocular fundus angiography and photodynamic therapy. Am J Ophthalmol 129 (2000) 353-362
65. Schmidt-Erfurth U., Hasan T., Flotte T., Gragoudas E., and Birngruber R. [Photodynamic therapy of experimental, intraocular tumors with benzoporphyrin-lipoprotein]. Ophthalmologe 91 (1994) 348-356
66. Schmidt-Erfurth U., Bauman W., Gragoudas E., et al. Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin. Ophthalmology 101 (1994) 89-99
67. Schmidt-Erfurth U., Hasan T., Gragoudas E., Michaud N., Flotte T.J., and Birngruber R. Vascular targeting in photodynamic occlusion of subretinal vessels. Ophthalmology 101 (1994) 1953-1961
68. Schmidt-Erfurth U., Flotte T.J., Gragoudas E.S., Schomacker K., Birngruber R., and Hasan T. Benzoporphyrin-lipoprotein-mediated photodestruction of intraocular tumors. Exp Eye Res 62 (1996) 1-10
69. Granville D.J., Levy J.G., and Hunt D.W. Photodynamic treatment with benzoporphyrin derivative monoacid ring A produces protein tyrosine phosphorylation events and DNA fragmentation in murine P815 cells. Photochem Photobiol 67 (1998) 358-362
70. Barbazetto I., and Schmidt-Erfurth U. Photodynamic therapy of choroidal hemangioma: two case reports. Graefes Arch Clin Exp Ophthalmol 238 (2000) 214-221
71. Panjehpour M., DeNovo R.C., Petersen M.G., et al. Photodynamic therapy using Verteporfin (benzoporphyrin derivative monoacid ring A, BPD-MA) and 630 nm laser light in canine esophagus. Lasers Surg Med 30 (2002) 26-30
72. Middelkamp-Hup M.A., Sanchez-Carpintero I., Kossodo S., et al. Photodynamic therapy for cutaneous proliferative vascular tumors in a mouse model. J Invest Dermatol 121 (2003) 634-639
73. Lofgren L.A., Ronn A.M., Abramson A.L., et al. Photodynamic therapy using m-tetra (hydroxyphenyl) chlorin. An animal model. Arch Otolaryngol Head Neck Surg 120 (1994) 1355-1362
74. Grosjean P., Savary J.F., Mizeret J., et al. Photodynamic therapy for cancer of the upper aerodigestive tract using tetra (m-hydroxyphenyl) chlorin. J Clin Laser Med Surg 14 (1996) 281-287
75. Savary J.F., Grosjean P., Monnier P., et al. Photodynamic therapy of early squamous cell carcinomas of the esophagus: a review of 31 cases. Endoscopy 30 (1998) 258-265
76. Gossner L., May A., Sroka R., and Ell C. A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia. Endoscopy 31 (1999) 370-376
77. Gupta G., Morton C.A., Whitehurst C., Moore J.V., and MacKie R.M. Photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin in the topical treatment of Bowen's disease and basal cell carcinoma. Br J Dermatol 141 (1999) 385-386
78. Glanzmann T., Forrer M., Blant S.A., et al. Pharmacokinetics and pharmacodynamics of tetra (m-hydroxyphenyl) chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements. J Photochem Photobiol B 57 (2000) 22-32
79. Nathan T.R., Whitelaw D.E., Chang S.C., et al. Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study. J Urol 168 (2002) 1427-1432
80. Copper M.P., Tan I.B., Oppelaar H., Ruevekamp M.C., and Stewart F.A. Meta-tetra (hydroxyphenyl) chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 129 (2003) 709-711
81. Friedberg J.S., Mick R., Stevenson J., et al. A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma. Ann Thorac Surg 75 (2003) 952-959
82. Jones H.J., Vernon D.I., and Brown S.B. Photodynamic therapy effect of m-THPC (Foscan) in vivo: correlation with pharmacokinetics. Br J Cancer 89 (2003) 398-404
83. Radu A., Conde R., Fontolliet C., Wagnieres G., Van den B.H., and Monnier P. Mucosal ablation with photodynamic therapy in the esophagus: optimization of light dosimetry in the sheep model. Gastrointest Endosc 57 (2003) 897-905
84. Taber S.W., Fingar V.H., Coots C.T., and Wieman T.J. Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study. Clin Cancer Res 4 (1998) 2741-2746
85. Katsumi T., Aizawa K., Okunaka T., et al. Photodynamic therapy using a diode laser with mono-L-aspartyl chlorin e6 for implanted fibrosarcoma in mice. Jpn J Cancer Res 85 (1994) 1165-1170
86. Spikes J.D., and Bommer J.C. Photobleaching of mono-L-aspartyl chlorin e6 (NPe6): a candidate sensitizer for the photodynamic therapy of tumors. Photochem Photobiol 58 (1993) 346-350
87. Spikes J.D., and Bommer J.C. Photosensitizing properties of mono-L-aspartyl chlorin e6 (NPe6): a candidate sensitizer for the photodynamic therapy of tumors. J Photochem Photobiol B 17 (1993) 135-143
88. Chang S.C., Chern I.F., and Hsu Y.H. Biological responses of dog prostate and adjacent structures after meso-tetra- (m-hydroxyphenyl) chlorin and aluminum disulfonated phthalocyanine based photodynamic therapy. Proc Natl Sci Counc Repub China B 23 (1999) 158-166
89. Colussi V.C., Feyes D.K., Mulvihill J.W., et al. Phthalocyanine 4 (Pc 4) photodynamic therapy of human OVCAR-3 tumor xenografts. Photochem Photobiol 69 (1999) 236-241
90. Kashtan H., Haddad R., Yossiphov Y., Bar-On S., and Skornick Y. Photodynamic therapy of colorectal cancer using a new light source: from in vitro studies to a patient treatment. Dis Colon Rectum 39 (1996) 379-383
91. Kostron H., Hochleitner B.W., Obwegeser A., and Seiwald M. Clinical and experimental results of photodynamic therapy in neurosurgery. Proc SPIE 2371 (1995) 126-128
92. Muller P.J., and Wilson B.C. Photodynamic therapy of malignant primary brain tumours: clinical effects, post-operative ICP, and light penetration of the brain. Photochem Photobiol 46 (1987) 929-935
93. Muller P.J., and Wilson B.C. Photodynamic therapy of malignant brain tumours. Can J Neurol Sci 17 (1990) 193-198
94. Perria C., Capuzzo T., Cavagnaro G., et al. First attempts at the photodynamic treatment of human gliomas. J Neurosurg Sci 24 (1980) 119-129
95. Stylli S.S., Howes M., MacGregor L., Rajendra P., and Kaye A.H. Photodynamic therapy of brain tumours: evaluation of porphyrin uptake versus clinical outcome. J Clin Neurosci 11 (2004) 584-596
96. Laws Jr. E.R., Cortese D.A., Kinsey J.H., Eagan R.T., and Anderson R.E. Photoradiation therapy in the treatment of malignant brain tumors: a phase I (feasibility) study. Neurosurgery 9 (1981) 672-678
97. Powers S.K., Cush S.S., Walstad D.L., and Kwock L. Stereotactic intratumoral photodynamic therapy for recurrent malignant brain tumors. Neurosurgery 29 (1991) 688-695
98. Perria C., Carai M., Falzoi A., et al. Photodynamic therapy of malignant brain tumors: clinical results of, difficulties with, questions about, and future prospects for the neurosurgical applications. Neurosurgery 23 (1988) 557-563
99. Kostron H., Fritsch E., and Grunert V. Photodynamic therapy of malignant brain tumours: a phase I/II trial. Br J Neurosurg 2 (1988) 241-248
100. Kostron H., Obwegeser A., and Jakober R. Photodynamic therapy in neurosurgery: a review. J Photochem Photobiol B 36 (1996) 157-168
101. Obwegeser A., Ortler M., Seiwald M., Ulmer H., and Kostron H. Therapy of glioblastoma multiforme: a cumulative experience of 10 years. Acta Neurochir (Wien) 137 (1995) 29-33
102. Muller P.J., and Wilson B.C. Photodynamic therapy: cavitary photoillumination of malignant cerebral tumours using a laser coupled inflatable balloon. Can J Neurol Sci 12 (1985) 371-373
103. Kaye A.H., Morstyn G., and Brownbill D. Adjuvant high-dose photoradiation therapy in the treatment of cerebral glioma: a phase 1-2 study. J Neurosurg 67 (1987) 500-505
104. Rosenthal M.A., Kavar B., Hill J.S., et al. Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin. J Clin Oncol 19 (2001) 519-524
105. Rosenthal M.A., Kavar B., Uren S., and Kaye A.H. Promising survival in patients with high-grade gliomas following therapy with a novel boronated porphyrin. J Clin Neurosci 10 (2003) 425-427
106. Masters B.R., So P.T., and Gratton E. Multiphoton excitation fluorescence microscopy and spectroscopy of in vivo human skin. Biophys J 72 (1997) 2405-2412
107. Konig K. Multiphoton microscopy in life sciences. J Microsc 200 Pt 2 (2000) 83-104
108. Svaasand L.O., and Ellingsen R. Optical penetration in human intracranial tumors. Photochem Photobiol 41 (1985) 73-76
109. Stylli S.S., Hill J.S., Sawyer W.H., and Kaye A.H. Aluminium phthalocyanine mediated photodynamic therapy in experimental malignant glioma. J Clin Neurosci 2 (1995) 146-151
110. Stylli S.S., Hill J.S., Sawyer W.H., and Kaye A.H. Phthalocyanine potosensitizers for the treatment of brain tumours. J Clin Neurosci 2 (1995) 64-72
111. Svaasand L.O. Optical dosimetry for direct and interstitial photoirradiation therapy of malignant tumors. In: Doiron D.R., and Gomer C.J. (Eds). Porphyrin Localization and Treatment of Tumors (1984), Alan R. Liss, New York 91-114
112. Svaasand L.O. Photodynamic and photohyperthermic response of malignant tumors. Med Phys 12 (1985) 455-461
113. Lilge L., and Wilson B.C. Photodynamic therapy of intracranial tissues: a preclinical comparative study of four different photosensitizers. J Clin Laser Med Surg 16 (1998) 81-91
114. Georgakoudi I., and Foster T.H. Singlet oxygen- versus nonsinglet oxygen-mediated mechanisms of sensitizer photobleaching and their effects on photodynamic dosimetry. Photochem Photobiol 67 (1998) 612-625
115. Georgakoudi I., Nichols M.G., and Foster T.H. The mechanism of Photofrin photobleaching and its consequences for photodynamic dosimetry. Photochem Photobiol 65 (1997) 135-144
116. Tudge S.H., Kaye A.H., and Hill J.S. Modulation of light delivery in photodynamic therapy of brain tumours. J Clin Neurosci 6 (1999) 227-232
117. Kaye A.H., and Morstyn G. Photoradiation therapy causing selective tumor kill in a rat glioma model. Neurosurgery 20 (1987) 408-415
118. Kostron H., Weiser G., Fritsch E., and Grunert V. Photodynamic therapy of malignant brain tumors: clinical and neuropathological results. Photochem Photobiol 46 (1987) 937-943
119. Stylli S.S., Kaye A.H., MacGregor L., Howes M., and Rajendra P. Photodynamic therapy of high grade glioma - long term survival. J Clin Neurosci 12 (2005) 385-394
120. Wilson B.C., Muller P.J., and Yanch J.C. Instrumentation and light dosimetry for intra-operative photodynamic therapy (PDT) of malignant brain tumours. Phys Med Biol 31 (1986) 125-133
121. Krishnamurthy S., Powers S.K., Witmer P., and Brown T. Optimal light dose for interstitial photodynamic therapy in treatment for malignant brain tumors. Lasers Surg Med 27 (2000) 224-234
122. Origitano T.C., and Reichman O.H. Photodynamic therapy for intracranial neoplasms: development of an image-based computer-assisted protocol for photodynamic therapy of intracranial neoplasms. Neurosurgery 32 (1993) 587-595
123. Cheng M.K., McKean J., Boisvert D., Tulip J., and Mielke B.W. Effects of photoradiation therapy on normal rat brain. Neurosurgery 15 (1984) 804-810
124. Henderson B.W., Waldow S.M., Potter W.R., and Dougherty T.J. Interaction of photodynamic therapy and hyperthermia: tumor response and cell survival studies after treatment of mice in vivo. Cancer Res 45 (1985) 6071-6077
125. Waldow S.M., Henderson B.W., and Dougherty T.J. Potentiation of photodynamic therapy by heat: effect of sequence and time interval between treatments in vivo. Lasers Surg Med 5 (1985) 83-94
126. Levendag P.C., Marijnissen H.P., de Ru V.J., Versteeg J.A., van Rhoon G.C., and Star W.M. Interaction of interstitial photodynamic therapy and interstitial hyperthermia in a rat rhabdomyosarcoma-a pilot study. Int J Radiat Oncol Biol Phys 14 (1988) 139-145
127. Leunig M., Leunig A., Lankes P., and Goetz A.E. Evaluation of photodynamic therapy-induced heating of hamster melanoma and its effect on local tumour eradication. Int J Hyperthermia 10 (1994) 297-306
128. Marijnissen J.P., Baas P., Beek J.F., van Moll J.H., van Zandwijk N., and Star W.M. Pilot study on light dosimetry for endobronchial photodynamic therapy. Photochem Photobiol 58 (1993) 92-99
129. Schmidt M.H., Meyer G.A., Reichert K.W., et al. Evaluation of photodynamic therapy near functional brain tissue in patients with recurrent brain tumors. J Neurooncol 67 (2004) 201-207
130. McCulloch G.A.J., Forbes I.J., and Lee See K. Phototherapy in malignant brain tumours. In: Doiron D.R., and Gomer C.J. (Eds). Porphyrin localization and treatment of tumours (1984), Alan R Liss, New York 709-717
131. Central Brain Tumor Registry of the United States : Statistical Report: Primary Brain Tumors of the United States, 1992-1997, 2000. Chicago, IL.
132. Kaneko SH, Kobayashi Y, Kohama Y. Stereotactic intratumoural photodynamic therapy on malignant brain tumours. International Symposium on Photodynamic Therapy in Clinical Practice. 1995.
133. Brown S.B., Brown E.A., and Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol 5 (2004) 497-508
134. Allison R.R., Downie G.H., Cuenca R., Huin-Hua X., Childs C.J.H., and Sibata C.H. Photosensitizers in clinical PDT. Photodiagnosis and Photodynamic Therapy 1 (2004) 27-42
135. Wharen Jr. R.E., Anderson R.E., and Laws Jr. E.R. Quantitation of hematoporphyrin derivative in human gliomas, experimental central nervous system tumors, and normal tissues. Neurosurgery 12 (1983) 446-450
136. Cappugi P., Mavilia L., Campolmi P., Reali E.F., Mori M., and Rossi R. New proposal for the treatment of nodular basal cell carcinoma with intralesional 5-aminolevulinic acid. J Chemother 16 (2004) 491-493
137. Claydon P.E., and Ackroyd R. 5-Aminolaevulinic acid-induced photodynamic therapy and photodetection in Barrett's esophagus. Dis Esophagus 17 (2004) 205-212
138. Dijkstra A.T., Majoie I.M., vanDongen J.W., vanWeelden H., and vanVloten W.A. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma. J Eur Acad Dermatol Venereol 15 (2001) 550-554
139. Kelty C.J., Ackroyd R., Brown N.J., Brown S.B., and Reed M.W. Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett's esophagus. Surg Endosc 18 (2004) 452-458
140. Barnett A.A., Haller J.C., Cairnduff F., Lane G., Brown S.B., and Roberts D.J. A randomised, double-blind, placebo-controlled trial of photodynamic therapy using 5-aminolaevulinic acid for the treatment of cervical intraepithelial neoplasia. Int J Cancer 103 (2003) 829-832
141. Wang I., Bendsoe N., Klinteberg C.A., et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 144 (2001) 832-840
142. Ortner M.E., Caca K., Berr F., et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 125 (2003) 1355-1363
143. Hendren S.K., Hahn S.M., Spitz F.R., et al. Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Ann Surg Oncol 8 (2001) 65-71
144. Panjehpour M., Overholt B.F., Haydek J.M., and Lee S.G. Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation. Am J Gastroenterol 95 (2000) 2177-2184
145. Pass H.I., Temeck B.K., Kranda K., et al. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol 4 (1997) 628-633
146. Pass H.I., DeLaney T.F., Tochner Z., et al. Intrapleural photodynamic therapy: results of a phase I trial. Ann Surg Oncol 1 (1994) 28-37
147. Kato H., Furukawa K., Sato M., et al. Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung. Lung Cancer 42 (2003) 103-111
148. Chan A.L., Juarez M., Allen R., Volz W., and Albertson T. Pharmacokinetics and clinical effects of mono-L-aspartyl chlorin e6 (NPe6) photodynamic therapy in adult patients with primary or secondary cancer of the skin and mucosal surfaces. Photodermatol Photoimmunol Photomed 21 (2005) 72-78
149. Moghissi K., Dixon K., Stringer M., Freeman T., Thorpe A., and Brown S. The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases. Eur J Cardiothorac Surg 15 (1999) 1-6
150. Moskal T.L., Dougherty T.J., Urschel J.D., et al. Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up. Ann Thorac Surg 66 (1998) 1128-1133
151. D'Cruz A.K., Robinson M.H., and Biel M.A. mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients. Head Neck 26 (2004) 232-240
152. Schouwink H., and Baas P. Foscan-mediated photodynamic therapy and operation for malignant pleural mesothelioma. Ann Thorac Surg 78 (2004) 388-389
153. Kubler A.C., Haase T., Staff C., Kahle B., Rheinwald M., and Muhling J. Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck. Lasers Surg Med 25 (1999) 60-68
154. Wierrani F., Fiedler D., Grin W., et al. Clinical effect of meso-tetrahydroxyphenylchlorine based photodynamic therapy in recurrent carcinoma of the ovary: preliminary results. Br J Obstet Gynaecol 104 (1997) 376-378